Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02435771 · ClinicalTrials.gov registry record · Phase 4
Efficacy Of Ergocalciferol In Adults According To BMI
A Phase 4 study, sponsored by Walter Reed National Military Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
NCT02435771 is a Phase 4 study that was terminated before completion, run by Walter Reed National Military Medical Center. The registered enrollment target is 44 participants.
The verdict
NCT02435771, a Phase 4 study, was terminated before completion, sponsored by Walter Reed National Military Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
Study Summary
Vitamin D insufficiency is an increasing trend in the United States. According to the NHANES data collection there was a near doubling of patients with vitamin D deficiency in 10 years. Vitamin D deficiency is associated with several adverse outcomes such as increased fractures, certain microbial diseases, cardiovascular diseases, and metabolic dysfunction. The increasing prevalence of vitamin D deficiency has been attributed to the increasing prevalence of obesity. Several studies have shown that obese patients have lower 25-OH vitamin D (25-OHD) levels compared to nonobese patients and obese patients require more vitamin D compared to nonobese patients. The most commonly prescribed medication to replete vitamin D deficiency is oral ergocalciferol. To date, no prospective trials have been published to evaluate a standard protocol in the treatment of vitamin D insufficiency in adults.
Interventions
- DRUG Ergocalciferols
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2011-07 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02435771
The ClinicalTrials.gov registry entry for NCT02435771 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed National Military Medical Center, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ergocalciferols is the first listed.
NCT02435771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02435771 about?
NCT02435771 is a clinical study titled "Efficacy Of Ergocalciferol In Adults According To BMI". Vitamin D insufficiency is an increasing trend in the United States. According to the NHANES data collection there was a near doubling of patients with vitamin D deficiency in 10 years. Vitamin D deficiency is associated with several adverse outcomes such as increased fractures, certain microbial di...
What is the current status of trial NCT02435771?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2011-07. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02435771?
The interventions under investigation include: Ergocalciferols (DRUG).
Who is sponsoring clinical trial NCT02435771?
This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.